Rosella Ciurleo

Papers

Total Citations

H-Index

About

Rosella Ciurleo is a leading researcher at the intersection of neurorehabilitation and pharmacology, with a primary focus on improving mobility and quality of life for individuals with multiple sclerosis (MS). Her work investigates how advanced therapeutic interventions can address gait disability and spasticity—two of the most debilitating symptoms of MS that remain resistant to conventional disease-modifying treatments. Ciurleo’s most cited paper, “The role of Sativex in robotic rehabilitation in individuals with multiple sclerosis” (2017, 12 citations), is a pioneering study that explores the synergistic potential of combining nabiximols (Sativex)—an oromucosal spray containing cannabinoids—with robotic-assisted gait training. This work highlights her innovative approach to integrating pharmacological and technological strategies to enhance motor recovery. By demonstrating how Sativex may reduce spasticity and improve walking outcomes when paired with robotic rehabilitation, Ciurleo has opened new avenues for personalized, multimodal treatment protocols in MS care. Her research is particularly impactful for clinicians and rehabilitation scientists seeking evidence-based solutions for chronic neurological disability, and it underscores her commitment to translating mechanistic insights into practical, patient-centered interventions.